To access the full text documents, please follow this link: http://hdl.handle.net/2445/59194
dc.contributor | Universitat de Barcelona |
---|---|
dc.contributor.author | Di Pietro, Ornella |
dc.contributor.author | Pérez-Areales, F. Javier |
dc.contributor.author | Juárez-Jiménez, Jordi |
dc.contributor.author | Espargaró Colomé, Alba |
dc.contributor.author | Clos Guillén, M. Victòria |
dc.contributor.author | Pérez Fernández, Belén |
dc.contributor.author | Lavilla Grífols, Rodolfo |
dc.contributor.author | Sabaté Lagunas, Raimon |
dc.contributor.author | Luque Garriga, F. Xavier |
dc.contributor.author | Muñoz-Torrero López-Ibarra, Diego |
dc.date | 2014-10-29T13:35:43Z |
dc.date | 2014-10-29T13:35:43Z |
dc.date | 2014-09-12 |
dc.date | 2014-10-29T13:35:43Z |
dc.identifier.citation | 0223-5234 |
dc.identifier.citation | 642499 |
dc.identifier.uri | http://hdl.handle.net/2445/59194 |
dc.format | 11 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Elsevier Masson SAS |
dc.relation | Versió postprint del document publicat a: http://dx.doi.org/10.1016/j.ejmech.2014.07.021 |
dc.relation | European Journal of Medicinal Chemistry, 2014, vol. 84, p. 107-117 |
dc.relation | http://dx.doi.org/10.1016/j.ejmech.2014.07.021 |
dc.rights | (c) Elsevier Masson SAS, 2014 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.subject | Disseny de medicaments |
dc.subject | Inhibidors enzimàtics |
dc.subject | Malaltia d'Alzheimer |
dc.subject | Pèptids |
dc.subject | Proteïnes |
dc.subject | Drug design |
dc.subject | Enzyme inhibitors |
dc.subject | Alzheimer's disease |
dc.subject | Peptides |
dc.subject | Proteins |
dc.title | Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting beta-amyloid, tau, and cholinesterase pathologies |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/acceptedVersion |
dc.description.abstract |